Skip to content

Simplexa COVID-19 Direct MOL4150Recalls & reported problems

Diasorin Molecular LLC · Class 2

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 20816101027020), received between Nov 13, 2024 and Nov 13, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “False Positive Result” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jan 30, 2023Open, Classified

    Direct amplification Discs , used with COVID-19 and Flu A/B & RSV assays, may leak and cause contamination, cross-contamination, invalid results, and error codes.

    Z-1209-2023 · Root cause: Device Design · FDA record ↗

Most reported problems

Device problems

  • False Positive Result1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 13, 2024False Positive Result; False Positive Result

    DIASORIN MOLECULAR LLC RECEIVED A COMPLAINT ON (B)(6) 2024, ALLEGING FALSE POSITIVE RESULTS WITH THE SIMPLEXA COVID-19 DIRECT ASSAY WITH ONLY 1 OF 2 TARGETS DETECTED (NO S-GENE, BUT ORF1AB DETECTED). UPON REPEAT ON A COMPETITOR ASSAY (BD-MAX), THE RESULTS WERE NEGATIVE. THE CUSTOMER CONFIRMED NO ALLEGED HARM OCCURRED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20679515 ↗

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.